External application of NF-κB inhibitor DHMEQ suppresses development of atopic dermatitis-like lesions induced with DNCB/OX in BALB/c mice-Reference-Cited by-同舟云学术

External application of NF-κB inhibitor DHMEQ suppresses development of atopic dermatitis-like lesions induced with DNCB/OX in BALB/c mice

Author:

Jiang Xiaoxue¹,Lan Yi¹,Wei Bing¹,Dai Cailing¹,Gu Yaru¹,Ma Jun²,Liu Xiaoyan²,Umezawa Kazuo³,Zhang Yuyang¹

Affiliation:

1. Department of Pharmacology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China;

2. Department of Research and Development, Shenzhen Wanhe Pharmaceutical Co., Ltd., Shenzhen, China;

3. Department of Molecular Target Medicine, Aichi Medical University School of Medicine, Nagakute, Japan

Funder

National Key Programs in Science and Technology-Discovery and Development of New Drugs with High Clinical Impact

Guangdong Provincial Programs for Achieving Core Technological Breakthroughs in Strategic Emerging Industries

Shenzhen Municipal Programs for the Research and Development of Technologies

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

Reference36 articles.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献